NIF Ventures (a member of Daiwa Securities Group) and SMBC Capital (a member of Sumitomo Mitsui Financial Group) merged on October 1, 2005 to form NIF SMBC Ventures. Both were well-established brands within the venture capital industry, being involved in listing various companies. After the merger, having grown out of a securities firm and a bank, NIF SMBC Ventures is a venture capital firm that maximizes use of its broad business network, longstanding experience and know-how while implementing investment operations. Disclaimer: the development of new drug technologies is difficult, erratic and unpredictable. Endotis Pharma's forecasts and future economic performance depend on research that has yet to be performed and on a number of other factors. The company's future economic performance may differ significantly from that currently forecast.
| Website | http://www.nif.co.jp |
| Revenue | $13.7 million |
| Employees | View employees |
| Phone | +81 3-5695-8250 |
| Industry | Finance General, Finance |
| Competitors | ジャフコ グループ, Incubate Fund, 赛博艾坚特(北京)投资咨询有限公司深圳分公司, Angel's Gate, GV (Google Ventures), DeNA, MIXI, Inc, gumi Inc., 株式会社アクア・ラボ, VentureFund +39 more (view full list) |
| SIC | SIC Code 679 Companies, SIC Code 67 Companies |
| NAICS | NAICS Code 523 Companies, NAICS Code 52 Companies, NAICS Code 5239 Companies |
Looking for a particular NIF Ventures employee's phone or email?
NIF Ventures Questions
The NIF Ventures annual revenue was $13.7 million in 2026.
The NAICS codes for NIF Ventures are [523, 52, 5239].
The SIC codes for NIF Ventures are [679, 67].
Related Companies
